The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Excitotoxic damage to white matter
Open accessAbstract
Glutamate kills neurons by excitotoxicity, which is caused by sustained activation of glutamate receptors. In recent years, it has been shown that glutamate can also be toxic to white matter oligodendrocytes and to myelin by this mechanism. In particular, glutamate receptor‐mediated injury to these cells can be triggered by activation of alpha‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid, kainate and N‐methyl‐d‐aspartate glutamate receptor types. Thus, these receptor classes, and the intermediaries of the signal cascades they activate, are potential targets for drug development to treat white matter damage in acute and chronic diseases. In addition, alterations of glutamate homeostasis in white matter can determine glutamate injury to oligodendrocytes and myelin. Astrocytes are responsible for most glutamate uptake in synaptic and non‐synaptic areas and consequently are the major regulators of glutamate homeostasis. Activated microglia in turn may secrete cytokines and generate radical oxygen species, which impair glutamate uptake and reduce the expression of glutamate transporters. Finally, oligodendrocytes also contribute to glutamate homeostasis. This review aims at summarizing the current knowledge about the mechanisms leading to oligodendrocyte cell death and demyelination as a consequence of alterations in glutamate signalling, and their clinical relevance to disease. In addition, we show evidence that oligodendrocytes can also be killed by ATP acting at P2X receptors. A thorough understanding of how oligodendrocytes and myelin are damaged by excitotoxicity will generate knowledge that can lead to improved therapeutic strategies to protect white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 1×
“Glutamate activates ionotropic and metabotropic receptors (for reviews, see Dingledine et al. 1999; CullCandy & Leszkiewicz, 2004; Swanson et al. 2005).”
BackgroundMolecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 1×
“Remarkably, clinically used betalactam antibiotics are also potent activators of GluT expression and thus hold great therapeutic potential (Rothstein et al. 2005).”
BackgroundThe changing landscape of ischaemic brain injury mechanisms
Lee, J.-M., Zipfel, G. J., & Choi, D. W. (1999) · Nature · doi:10.1038/399a007 · Cited by 1,102 · cited 1×
“Excitotoxic cell death can occur in virtually all neurons which express ionotropic glutamate receptors (GluRs) and it has been implicated in acute injury to the central nervous system (CNS) and in chronic neurodegenerative disorders (Choi, 1988; Lipton & Rosenberg, 1994; Lee et al. 1999).”
BackgroundRole of Distinct NMDA Receptor Subtypes at Central Synapses
Cull-Candy, S. G., & Leszkiewicz, D. N. (2004) · Science's STKE · doi:10.1126/stke.2552004re16 · Cited by 804
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.443 · Cited by 793
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia
Káradóttir, R., Cavelier, P., Bergersen, L. H., & Attwell, D. (2005) · Nature · doi:10.1038/nature04302 · Cited by 772
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Cytokines in inflammatory brain lesions: helpful and harmful
Merrill, J. E., & Benveniste, E. N. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10047-3 · Cited by 722
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A., & Schoepp, D. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1630 · Cited by 607
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
Mcdonald, J. W., Althomsons, S. P., Hyrc, K. L., Choi, D. W., & Goldberg, M. P. (1998) · Nature Medicine · doi:10.1038/nm0398-291 · Cited by 544
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia
Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., Yin, X., Trapp, B. D., McRory, J. E., Rehak, R., et al. (2006) · Nature · doi:10.1038/nature04474 · Cited by 505
Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention
Oka, A., Belliveau, M., Rosenberg, P., & Volpe, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01441.1993 · Cited by 504
P2X7 receptor inhibition improves recovery after spinal cord injury
Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1082 · Cited by 494
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 486
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., & Pelletier, D. (2005) · Brain · doi:10.1093/brain/awh467 · Cited by 465
Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
Volterra, A., Trotti, D., Tromba, C., Floridi, S., & Racagni, G. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02924.1994 · Cited by 461
Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia
Haynes, R. L., Folkerth, R. D., Keefe, R. J., Sung, I., Swzeda, L. I., Rosenberg, P. A., Volpe, J. J., & Kinney, H. C. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.5.441 · Cited by 454
Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
Matute, C., Sánchez-Gómez, M. V., Martínez-Millán, L., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8830 · Cited by 352 · cited 4×
“More recently, it was shown that prolonged activation of GluRs is toxic to cells of an oligodendroglial cell line (Yoshioka et al. 1996) and to oligodendrocytes in vitro and in vivo (Matute et al. 1997; McDonald et al. 1998; Li & Stys, 2000).”
BackgroundInfluentialSelf-citationThe link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
Self-citationOligodendrocytes and Ischemic Brain Injury
Dewar, D., Underhill, S. M., & Goldberg, M. P. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000053472.41007.f9 · Cited by 335 · cited 1×
“Energy deprivation causes neuronal death, axonal dysfunction and loss of oligodendrocytes which are very sensitive to transient oxygen and glucose deprivation (Dewar et al. 2003; Goldberg & Ransom, 2003; Stys, 2004).”
BackgroundGlutamate‐mediated glial injury: Mechanisms and clinical importance
Matute, C., Domercq, M., & Sánchez‐Gómez, M. (2006) · Glia · doi:10.1002/glia.20275 · Cited by 330
Self-citationRapid Ischemic Cell Death in Immature Oligodendrocytes: A Fatal Glutamate Release Feedback Loop
Fern, R., & Möller, T. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00034.2000 · Cited by 320
Taylor, D. L., Jones, F., Kubota, E. S. F. C. S., & Pocock, J. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-04.2005 · Cited by 308
Li, S., & Stys, P. K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01190.2000 · Cited by 307
Glutamate transporters bring competition to the synapse
Huang, Y. H., & Bergles, D. E. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.007 · Cited by 269
Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity
Takahashi, J. L., Giuliani, F., Power, C., Imai, Y., & Yong, V. W. (2003) · Annals of Neurology · doi:10.1002/ana.10519 · Cited by 256
White Matter Injury Mechanisms
Stys, P. (2004) · Current Molecular Medicine · doi:10.2174/1566524043479220 · Cited by 252
Novel Role of Vitamin K in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons
Li, J., Lin, J. C., Wang, H., Peterson, J. W., Furie, B. C., Furie, B., Booth, S. L., Volpe, J. J., & Rosenberg, P. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05816.2003 · Cited by 249
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
Pitt, D., Nagelmeier, I. E., Wilson, H. C., & Raine, C. S. (2003) · Neurology · doi:10.1212/01.wnl.0000090564.88719.37 · Cited by 222
Neuroprotection by tetracyclines
Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205
Self-citationSelective Glial Vulnerability following Transient Global Ischemia in Rat Brain
Petito, C. K., Olarte, J.-P., Roberts, B., Nowak, T. S., & Pulsinell, W. A. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199803000-00004 · Cited by 205
Su, Z.-Z., Leszczyniecka, M., Kang, D.-C., Sarkar, D., Chao, W., Volsky, D. J., & Fisher, P. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136555100 · Cited by 199
Emerging concepts in periventricular white matter injury
Back, S. A., & Rivkees, S. A. (2004) · Seminars in Perinatology · doi:10.1053/j.semperi.2004.10.010 · Cited by 195
Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress
Deng, W., Wang, H., Rosenberg, P. A., Volpe, J. J., & Jensen, F. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307850101 · Cited by 179
Neurotransmitters in cerebrospinal fluid reflect pathological activity
STOVER, J. F., PLEINES, U. E., MORGANTI‐KOSSMANN, M. C., KOSSMANN, T., LOWITZSCH, K., & KEMPSKI, O. S. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2250774.x · Cited by 170
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 158
Sánchez‐Gómez, M. V., Alberdi, E. M., Ibarretxe, G., Torre, I., & Matute, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09519.2003 · Cited by 154
Self-citationAMPA and Kainate Receptors Each Mediate Excitotoxicity in Oligodendroglial Cultures
Sánchez‐Gómez, M. V., & Matute, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0264 · Cited by 153
Self-citationIncreased expression and function of glutamate transporters in multiple sclerosis
Vallejo‐Illarramendi, A., Domercq, M., Pérez‐Cerdá, F., Ravid, R., & Matute, C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.017 · Cited by 145
Self-citationPathophysiology of oligodendroglial excitotoxicity
Yoshioka, A., Bacskai, B. J., & Pleasure, D. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961115)46:4<427::aid-jnr4>3.0.co;2-i · Cited by 135
Yoshioka, A., Hardy, M., Younkin, D. P., Grinspan, J. B., Stern, J. L., & Pleasure, D. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062442.x · Cited by 134
Romera, C., Hurtado, O., Botella, S. H., Lizasoaín, I., Cárdenas, A., Fernández-Tomé, P., Leza, J. C., Lorenzo, P. L., & Moro, M. Á. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1596-03.2004 · Cited by 130
Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve
Matute, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10229 · Cited by 127
Self-citationIschemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia
Mandai, K., Matsumoto, M., Kitagawa, K., Matsushita, K., Ohtsuki, T., Mabuchi, T., Colman, D., Kamada, T., & Yanagihara, T. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00517-9 · Cited by 125
Expression of glutamate transporters in rat optic nerve oligodendrocytes
Domercq, M., Sánchez‐Gómez, M. V., Areso, P., & Matute, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00639.x · Cited by 125
Self-citationRole of P2X 7 Receptors in Ischemic and Excitotoxic Brain Injury In Vivo
Feuvre, R. A. L., Brough, D., Touzani, O., & Rothwell, N. J. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048519.34839.97 · Cited by 122
Periventricular Leukomalacia: Overview and Recent Findings
Folkerth, R. D. (2006) · Pediatric and Developmental Pathology · doi:10.2350/06-01-0024.1 · Cited by 122
Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition
Domercq, M., Etxebarria, E., Pérez‐Samartín, A., & Matute, C. (2005) · Glia · doi:10.1002/glia.20221 · Cited by 121
Self-citationGoldberg, M. P., & Ransom, B. R. (2003) · Stroke · doi:10.1161/01.str.0000054048.22626.b9 · Cited by 118
Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis
Kanwar, J. R., Kanwar, R. K., & Krissansen, G. W. (2004) · Brain · doi:10.1093/brain/awh156 · Cited by 114
Multiple Sclerosis and Glutamate
Groom, A., Smith, T., & Turski, L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07533.x · Cited by 109
Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack
Alberdi, E. M., Sánchez‐Gómez, M. V., Torre, I., Domercq, M., Pérez‐Samartín, A., Pérez‐Cerdá, F., & Matute, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3780-05.2006 · Cited by 96
Self-citationOligodendrocyte NMDA receptors: a novel therapeutic target
Matute, C. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.004 · Cited by 82
Self-citationAlberdi, E. M., Sánchez‐Gómez, M. V., & Matute, C. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.020 · Cited by 77
Self-citationChanges in neurotransmitters in multiple sclerosis
Vp, B., Завалишин, И. А., Аскарова, Л. Ш., Shavratskii, V. K., & Demina, E. G. (1998) · Neuroscience and Behavioral Physiology · doi:10.1007/bf02464784 · Cited by 68
Synaptic and extrasynaptic neurotransmitter receptors in glial precursors' quest for identity
Belachew, S. M., & Gallo, V. (2004) · Glia · doi:10.1002/glia.20077 · Cited by 60
Gottlieb, M., Domercq, M., & Matute, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200004000-00005 · Cited by 53
Self-citationAustralians seek international allies in battle over uranium mine
Pockley, P. (1999) · Nature · doi:10.1038/19819 · Cited by 40
Receptors for Neurotransmitters and Hormones
Kettenmann, H., & Steinhäuser, C. (2004) · Neuroglia · doi:10.1093/acprof:oso/9780195152227.003.0010 · Cited by 34
Cited by
White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723
“Myelin loss and the inability of the oligodendrocytes, the cells responsible for the production and maintenance of myelin, to repair myelin damage may be additional central features of AD [5, 53, 55, 60].”
Brain Tissue Responses to Neural Implants Impact Signal Sensitivity and Intervention Strategies
Kozai, T. D. Y., Jaquins-Gerstl, A. S., Vazquez, A. L., Michael, A. C., & Cui, X. T. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500256e · Cited by 622
The developing oligodendrocyte: key cellular target in brain injury in the premature infant
Volpe, J. J., Kinney, H. C., Jensen, F. E., & Rosenberg, P. A. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.02.012 · Cited by 394
Alberdi, E., Sánchez-Gómez, M. V., Cavaliere, F., Pérez-Samartín, A., Zugaza, J. L., Trullas, R., Domercq, M., & Matute, C. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.010 · Cited by 364
Self-citationNeuroinflammation and white matter pathology in schizophrenia: systematic review
Najjar, S., & Pearlman, D. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.041 · Cited by 319
Metadata
- Authors
- Matute, C., Alberdi, E., Domercq, M., Sánchez‐Gómez, M., Pérez‐Samartín, A., Rodríguez‐Antigüedad, A., & Pérez‐Cerdá, F.
- Venue
- Journal of Anatomy
- Publisher
- Wiley
- Published
- 2007-05-15
- Volume
- 210
- Issue
- 6
- Pages
- 693-702
- ISSN
- 0021-8782 (ISSN-L)
- 1469-7580
- OpenAlex
- W2026688064
- Cited by
- 259
- References
- 69
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.